Effects of the sodium-glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b-4 chronic kidney disease
- PMID: 29762740
- PMCID: PMC6031052
- DOI: 10.1093/ndt/gfy135
Effects of the sodium-glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b-4 chronic kidney disease
Erratum for
-
Effects of the sodium-glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b-4 chronic kidney disease.Nephrol Dial Transplant. 2018 Nov 1;33(11):2005-2011. doi: 10.1093/ndt/gfx350. Nephrol Dial Transplant. 2018. PMID: 29370424 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources